ondansetron
If you have any further questions, ask your doctor or pharmacist.
Contents of the pack
Yatrox belongs to a group of medicines called antiemetics. Yatrox is used to:
If you think any of these apply to you, talk to your doctor before taking Yatrox.
Talk to your doctor or pharmacist before taking Yatrox.
If you are going to have any diagnostic tests (including blood tests, urine tests, skin tests using allergens, etc.), tell your doctor that you are taking this medicine, as it may affect the results.
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.
In particular, it is important to tell your doctor if you are taking any of the following medicines, as it may be necessary to stop treatment or adjust the dose of one of them:
Tell your doctor or pharmacist if you are taking any of these medicines.
Yatrox should not be used during the first trimester of pregnancy. This is because Yatrox may slightly increase the risk of a baby being born with a cleft lip and/or cleft palate. If you are already pregnant, think you might be pregnant or are planning to become pregnant, talk to your doctor or pharmacist before taking Yatrox. If you are a woman of childbearing age, you are advised to use an effective method of contraception.
It is unlikely that Yatrox will affect your ability to drive or use machines.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, talk to your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
Remember to take your medicine. Swallow the tablets whole with a little water. Your doctor will tell you how long to take Yatrox for. Do not stop treatment early.
Adults
Two tablets (8 mg) by mouth, 1-2 hours before the medical treatment that is likely to cause nausea and vomiting, and then 2 tablets (8 mg) 12 hours later.
To prevent nausea and vomiting on subsequent days, continue taking 2 tablets (8 mg) every 12 hours for 5 days.
Children over 6 months and adolescents
Your doctor will decide the dose based on your child's weight or body surface area.
Normally, 12 hours after chemotherapy, your child will be given ondansetron by mouth. The usual dose is 4 mg twice a day and may continue for up to 5 days.
Adults
To prevent nausea and vomiting after surgery, 4 tablets (16 mg) by mouth, 1 hour before anesthesia.
Children
No data are available on the oral administration of ondansetron in the prevention of post-operative nausea and vomiting in children.
Patient with liver impairment
In patients with liver problems, the dose should be adjusted to a maximum of 8 mg per day of ondansetron.
Patients with advanced age, patients with kidney impairment or slow metabolizers of sparteine/debrisoquine
No dose adjustment is necessary.
Your doctor will decide the duration of your treatment with Yatrox. Do not stop treatment early.
If you think the effect of this medicine is too strong or too weak, talk to your doctor or pharmacist.
In case of overdose, the symptoms that may appear are: vision problems, low blood pressure (which can cause dizziness or fainting) and palpitations (irregular heartbeat).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
Do not take a double dose to make up for forgotten doses. Do not increase or decrease the dose without consulting your doctor.
If you forget to take a dose and have nausea or vomiting, take another dose as soon as possible. Then, continue taking the medicine as directed.
If you forget to take a dose and do not have nausea or vomiting, wait for the next dose and continue taking the medicine as directed.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Yatrox can cause side effects, although not everybody gets them.
May affect more than 1 in 10 people taking Yatrox:
May affect up to 1 in 10 people taking Yatrox:
May affect up to 1 in 100 people taking Yatrox:
May affect less than 1 in 1,000 people taking Yatrox:
If you experience any of these symptoms, stop taking the medicine immediately and contact your doctor.
May affect less than 1 in 10,000 people taking Yatrox:
Inform your doctor immediately if you experience any of these symptoms.
Side effects of unknown frequency: cannot be estimated from the available data
The signs include:
If you experience side effects, talk to your doctor, pharmacist or nurse, even if they are not listed in this leaflet.
Reporting of side effects
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active substance is ondansetron hydrochloride dihydrate. Each film-coated tablet of Yatrox contains 4 mg of ondansetron (as hydrochloride dihydrate).
The other ingredients are: lactose monohydrate, microcrystalline cellulose (E460), pregelatinized corn starch, magnesium stearate (E470b), hypromellose (E464), titanium dioxide (E171) and polyethylene glycol 400 (E1521).
Yatrox 4 mg are white, oblong, biconvex film-coated tablets with the inscription “4” on one side.
Yatrox is available in packs of 6, 15 or 500 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Dari Pharma, S.L.U.
Gran Via Carles III, 98, 10th floor
08028 Barcelona
Spain
Manufacturer
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí – Barcelona
Spain
Date of last revision of this leaflet:February 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS): http://www.aemps.gob.es/